Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Accumulated Depreciation (2020 - 2022)

Historic Accumulated Depreciation for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2022 value amounting to $1.4 million.

  • Terns Pharmaceuticals' Accumulated Depreciation rose 1831.22% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.4 million, marking a year-over-year increase of 1831.22%. This contributed to the annual value of $1.4 million for FY2022, which is 1831.22% up from last year.
  • Per Terns Pharmaceuticals' latest filing, its Accumulated Depreciation stood at $1.4 million for Q4 2022, which was up 1831.22% from $1.2 million recorded in Q4 2021.
  • In the past 5 years, Terns Pharmaceuticals' Accumulated Depreciation ranged from a high of $1.4 million in Q4 2022 and a low of $689000.0 during Q4 2020
  • Moreover, its 3-year median value for Accumulated Depreciation was $1.2 million (2021), whereas its average is $1.1 million.
  • As far as peak fluctuations go, Terns Pharmaceuticals' Accumulated Depreciation skyrocketed by 7198.84% in 2021, and later skyrocketed by 1831.22% in 2022.
  • Over the past 3 years, Terns Pharmaceuticals' Accumulated Depreciation (Quarter) stood at $689000.0 in 2020, then surged by 71.99% to $1.2 million in 2021, then grew by 18.31% to $1.4 million in 2022.
  • Its Accumulated Depreciation was $1.4 million in Q4 2022, compared to $1.2 million in Q4 2021 and $689000.0 in Q4 2020.